Ocugen to seek emergency nod for Covaxin from Health Canada
Published
Bharat Biotech’s US partner Ocugen said it will be seeking an emergency use nod for India’s first indigenously developed Covid-19 vaccine Covaxin from the Canadian health authorities. The company said it has already initiated discussions with Health Canada to seek regulatory approval.
Full Article